Literature DB >> 19858293

Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene expression and tumor growth.

Adam J Krieg1, Erinn B Rankin, Denise Chan, Olga Razorenova, Sully Fernandez, Amato J Giaccia.   

Abstract

The hypoxia-inducible transcription factors (HIFs) directly and indirectly mediate cellular adaptation to reduced oxygen tensions. Recent studies have shown that the histone demethylase genes JMJD1A, JMJD2B, and JARID1B are HIF targets, suggesting that HIFs indirectly influence gene expression at the level of histone methylation under hypoxia. In this study, we identify a subset of hypoxia-inducible genes that are dependent on JMJD1A in both renal cell and colon carcinoma cell lines. JMJD1A regulates the expression of adrenomedullin (ADM) and growth and differentiation factor 15 (GDF15) under hypoxia by decreasing promoter histone methylation. In addition, we demonstrate that loss of JMJD1A is sufficient to reduce tumor growth in vivo, demonstrating that histone demethylation plays a significant role in modulating growth within the tumor microenvironment. Thus, hypoxic regulation of JMJD1A acts as a signal amplifier to facilitate hypoxic gene expression, ultimately enhancing tumor growth.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19858293      PMCID: PMC2798291          DOI: 10.1128/MCB.00444-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  57 in total

Review 1.  High-throughput screening of chromatin immunoprecipitates using CpG-island microarrays.

Authors:  Matthew J Oberley; Julissa Tsao; Patrick Yau; Peggy J Farnham
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

2.  The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36.

Authors:  Robert J Klose; Kenichi Yamane; Yangjin Bae; Dianzheng Zhang; Hediye Erdjument-Bromage; Paul Tempst; Jiemin Wong; Yi Zhang
Journal:  Nature       Date:  2006-05-28       Impact factor: 49.962

3.  A signature motif in transcriptional co-activators mediates binding to nuclear receptors.

Authors:  D M Heery; E Kalkhoven; S Hoare; M G Parker
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

4.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

5.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

7.  Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases.

Authors:  Johnathan R Whetstine; Amanda Nottke; Fei Lan; Maite Huarte; Sarit Smolikov; Zhongzhou Chen; Eric Spooner; En Li; Gongyi Zhang; Monica Colaiacovo; Yang Shi
Journal:  Cell       Date:  2006-04-06       Impact factor: 41.582

8.  Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype.

Authors:  Linda Holmquist-Mengelbier; Erik Fredlund; Tobias Löfstedt; Rosa Noguera; Samuel Navarro; Helén Nilsson; Alexander Pietras; Johan Vallon-Christersson; Ake Borg; Katarina Gradin; Lorenz Poellinger; Sven Påhlman
Journal:  Cancer Cell       Date:  2006-11       Impact factor: 31.743

9.  Hypoxia induces a novel signature of chromatin modifications and global repression of transcription.

Authors:  Amber Buescher Johnson; Nicholas Denko; Michelle Craig Barton
Journal:  Mutat Res       Date:  2008-01-16       Impact factor: 2.433

10.  A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy.

Authors:  Sandra Turcotte; Denise A Chan; Patrick D Sutphin; Michael P Hay; William A Denny; Amato J Giaccia
Journal:  Cancer Cell       Date:  2008-07-08       Impact factor: 31.743

View more
  167 in total

1.  Buckley-James boosting for survival analysis with high-dimensional biomarker data.

Authors:  Zhu Wang; C Y Wang
Journal:  Stat Appl Genet Mol Biol       Date:  2010-06-08

2.  Retraction note to: KDM3A confers metastasis and chemoresistance in epithelial ovarian cancer.

Authors: 
Journal:  J Mol Histol       Date:  2015-12       Impact factor: 2.611

3.  p300-Mediated Acetylation of Histone Demethylase JMJD1A Prevents Its Degradation by Ubiquitin Ligase STUB1 and Enhances Its Activity in Prostate Cancer.

Authors:  Songhui Xu; Lingling Fan; Hee-Young Jeon; Fengbo Zhang; Xiaolu Cui; McKayla B Mickle; Guihong Peng; Arif Hussain; Ladan Fazli; Martin E Gleave; Xuesen Dong; Jianfei Qi
Journal:  Cancer Res       Date:  2020-06-10       Impact factor: 12.701

4.  Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1α.

Authors:  W Wan; K Peng; M Li; L Qin; Z Tong; J Yan; B Shen; C Yu
Journal:  Oncogene       Date:  2017-03-06       Impact factor: 9.867

5.  Histone demethylases and their roles in cancer epigenetics.

Authors:  Alexandra D'Oto; Qing-Wu Tian; Andrew M Davidoff; Jun Yang
Journal:  J Med Oncol Ther       Date:  2016

6.  Downregulation of histone demethylase JMJD1C inhibits colorectal cancer metastasis through targeting ATF2.

Authors:  Cheng Chen; Maimaiti Aihemaiti; Xin Zhang; Hui Qu; Qi-Long Sun; Qing-Si He; Wen-Bin Yu
Journal:  Am J Cancer Res       Date:  2018-05-01       Impact factor: 6.166

Review 7.  Epigenetics and the environment: in search of the "toleroasome" vital to execution of ischemic preconditioning.

Authors:  David Brand; Rajiv R Ratan
Journal:  Transl Stroke Res       Date:  2013-01-08       Impact factor: 6.829

8.  Control of histone H3 lysine 9 (H3K9) methylation state via cooperative two-step demethylation by Jumonji domain containing 1A (JMJD1A) homodimer.

Authors:  Satoshi Goda; Takayuki Isagawa; Yoko Chikaoka; Takeshi Kawamura; Hiroyuki Aburatani
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

Review 9.  The control of histone methylation and gene expression by oxidative stress, hypoxia, and metals.

Authors:  Yana Chervona; Max Costa
Journal:  Free Radic Biol Med       Date:  2012-07-25       Impact factor: 7.376

10.  Elevated JMJD1A is a novel predictor for prognosis and a potential therapeutic target for gastric cancer.

Authors:  Haiyan Yang; Zhenguo Liu; Cuncun Yuan; Yunfei Zhao; Lei Wang; Jiong Hu; Dacheng Xie; Liwei Wang; Donghui Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.